Compare Eaton Corporation plc (ETN) vs Eli Lilly And Co (LLY) Price & Performance

Eaton (ETN) trades at $424.51, down 1.58% over the past day, amid a bearish technical signal. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Strong profitability metrics include a 12.75% net income margin and 19.71% ROE. Recent news highlights strategic acquisitions in data center and utility markets, positioning the company for durable growth from AI and grid modernization trends.

Outlook remains positive with a consensus price target of $502.38, implying significant upside. Risks include execution of acquisitions and potential margin pressure from increased investing outlays. Analyst sentiment is strongly bullish with 70% buy ratings, though technical indicators suggest near-term caution.

Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company demonstrates exceptional profitability with 83.4% gross margins and 33.53% net income margins, supported by dominant positioning in weight-loss and diabetes treatments. Recent clinical trial successes for next-generation drugs and expanded FDA approvals reinforce growth prospects.

LLY presents compelling growth potential with analyst consensus target of $1,350 representing 15% upside, though elevated valuations (P/E 39.26) and increasing competition in obesity drugs pose risks. Strong institutional support (73% buy ratings) and positive pipeline developments support continued momentum, but investors should monitor execution risks and market saturation concerns.